Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


Brief Summary

GUIDELINE TITLE

Jaundice.

BIBLIOGRAPHIC SOURCE(S)

  • Foley WD, Bree RL, Gay SB, Glick SN, Heiken JP, Huprich JE, Levine MS, Ros PR, Rosen MP, Shuman WP, Greene FL, Expert Panel on Gastrointestinal Imaging. Jaundice. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 6 p. [24 references]

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Balfe DM, Ralls PW, Bree RL, DiSantis DJ, Glick SN, Levine MS, Megibow AJ, Saini S, Shuman WP, Greene FL, Laine LA, Lillemoe K, Kidd R. Imaging strategies in the initial evaluation of the jaundiced patient. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):125-33.

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

BRIEF SUMMARY CONTENT

 
RECOMMENDATIONS
 EVIDENCE SUPPORTING THE RECOMMENDATIONS
 IDENTIFYING INFORMATION AND AVAILABILITY
 DISCLAIMER

 Go to the Complete Summary

RECOMMENDATIONS

MAJOR RECOMMENDATIONS

ACR Appropriateness Criteria®

Clinical Condition: Jaundice

Variant 1: Acute abdominal pain; at least one of the following: fever, history of biliary surgery, known cholelithiasis.

Radiologic Exam Procedure Appropriateness Rating Comments
CT, abdomen 7  
MRI, abdomen, MRCP 5  
NUC, Cholescintigraphy 2  
Appropriateness Criteria Scale
1 2 3 4 5 6 7 8 9
1 = Least appropriate 9 = Most appropriate

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 2: Painless; one or more of the following: weight loss, fatigue, anorexia, duration of symptoms greater than 3 months. Patient otherwise healthy.

Radiologic Exam Procedure Appropriateness Rating Comments
CT, abdomen, dynamic multiplanar or helical 8  
US, abdomen 8  
MRI, abdomen, with MRCP 7  
INV, ERCP and EUS 6  
INV, PTC 4  
Appropriateness Criteria Scale
1 2 3 4 5 6 7 8 9
1 = Least appropriate 9 = Most appropriate

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 3: Painless; one or more of the following: weight loss, fatigue, anorexia, duration of symptoms greater than 3 months. Patient will not tolerate radical surgical procedure.

Radiologic Exam Procedure Appropriateness Rating Comments
INV, ERCP and EUS 8  
US, abdomen 8  
CT, abdomen, dynamic multiplanar or helical 8  
MRI, abdomen, with MRCP 7  
INV, PTC 5  
NUC, Cholescintigraphy 2  
Appropriateness Criteria Scale
1 2 3 4 5 6 7 8 9
1 = Least appropriate 9 = Most appropriate

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 4: Clinical condition and laboratory examination makes mechanical obstruction unlikely.

Radiologic Exam Procedure Appropriateness Rating Comments
US, abdomen 8  
CT, abdomen 5  
MRI, abdomen, with MRCP 5  
NUC, Nuclear medicine 4  
INV, ERCP and EUS 4  
INV, PTC 2  
Appropriateness Criteria Scale
1 2 3 4 5 6 7 8 9
1 = Least appropriate 9 = Most appropriate

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Variant 5: Confusing clinical picture; patient not described in previous scenarios.

Radiologic Exam Procedure Appropriateness Rating Comments
US, abdomen 8  
CT, abdomen 8  
INV, ERCP 6  
MRI, abdomen 6  
Appropriateness Criteria Scale
1 2 3 4 5 6 7 8 9
1 = Least appropriate 9 = Most appropriate

Note: Abbreviations used in the tables are listed at the end of the "Major Recommendations" field.

Appropriateness Criteria

To determine the appropriateness of any imaging test, it is necessary to consider the general clinical category to which the patient belongs. The major categories are (1) high likelihood of mechanical obstruction; (2) low likelihood of mechanical obstruction; and (3) indeterminate. For situations in which the pre-imaging probability for obstruction is high, it is also appropriate to consider a secondary question: whether the obstruction is likely to be benign or malignant.

Situation 1A: High Likelihood of Benign Biliary Obstruction

Patients in this category present with jaundice and acute abdominal pain. There may be a prior history of gallstones documented by sonography or of prior biliary surgery. Sonography is an accurate and the least expensive method for detecting dilated intrahepatic bile ducts and the common hepatic duct at the hepatic hilum. Biliary ductal calculi are not detected with the same sensitivity as gallbladder calculi. The subhepatic common duct is not visible in a high proportion of patients due to overlaying bowel gas. In addition, intrahepatic bile ducts may not be dilated in the early phase of acute obstruction or in patients with partial obstruction.

ERCP though invasive and expensive, is the most sensitive technique for detecting biliary calculi and endoscopic sphincterotomy, and associated therapeutic interventions may be curative. Appropriate patient selection, based on established clinical criteria, significantly improves the diagnostic yield of ERCP. IF ERCP cannot be performed (for example, in patients with previous gastroenteric anastomoses) or if attempted ERCP is unsuccessful or inadequate, MRCP is the most sensitive noninvasive method to document the presence of biliary calculi.

In patients with a history of prior surgery or suspected sclerosing cholangitis, in whom biliary stricture is a diagnostic consideration, MRCP is the preferred imaging test, avoiding the possibility of suppurative cholangitis that may be induced by endoscopic catheter manipulation into an obstructed biliary system. MRCP findings may guide directed approaches such as ERCP with brushing, percutaneous transhepatic biliary stenting or reconstructive surgery.

Situation 1B: High Likelihood of Malignant Biliary Obstruction  

Patients in this category typically present with insidious development of jaundice and associated constitutional symptoms (weight loss, fatigue, etc.). Mechanical biliary obstruction can be confirmed by sonography. Malignant obstruction is most commonly due to pancreatic carcinoma but may be secondary to cholangiocarcinoma of either the proximal or distal duct or to periductal nodal compression. A contrast-enhanced multipass CT examination with multiplanar reformation has high sensitivity to lesion detection and 70% accuracy in discrimination of resectable and unresectable disease. Important information in tumor staging includes tumor contiguity or invasion of the superior mesenteric and portal vein, peripancreatic tumor extension, regional adenopathy, and hepatic metastases. Contrast-enhanced multipass CT has 70% accuracy in tumor staging.

MR and MRCP are also accurate in tumor detection and staging. There are no wide scale comparative studies of CT and MRI in the evaluation of malignant biliary obstruction. CT is generally more available and more frequently used, with MRI/MRCP reserved for patients with contraindications to CT.

ERCP is invasive and more expensive than CT or MRI, has equivalent sensitivity in tumor detection, but does not provide staging information for operability. Tissue diagnosis can be obtained by endoscopically directed brushing or guided ultrasound with fine needle aspiration (FNA). In patients with pancreaticobiliary cancer who are surgical candidates, there is no established role for preoperative biliary drainage by ERCP. However, endoscopic biliary drainage may be used for operative candidates in whom there is delay prior to surgery. Endoscopic or percutaneous transhepatic biliary drainage is appropriate for patients who are not candidates for surgery, the percutaneous transhepatic technique being preferred for patients with hilar biliary obstruction.

In patients with suspected malignant biliary obstruction and negative or equivocal CT or MRI studies, ERCP with EUS may provide an imaging and cytologic diagnosis (FNA).

Cytological tumor diagnosis in nonoperative candidates can be obtained either by EUS directed brushing or FNA, US directed or CT directed pancreatic or nodal biopsy of by fluoroscopically guided brushing or FNA (PTC).

Focal chronic pancreatitis may mimic pancreatic carcinoma on all imaging tests and only be conclusively diagnosed on operative exploration and biopsy.

Periductal nodal compression may result from metastatic disease or malignant lymphoma. Diagnosis is usually based on imaging appearances and clinical history. Tissue confirmation may be obtained by imaging directed percutaneous biopsy.

Situation 2: Low Likelihood of Mechanical Biliary Obstruction

In situations in which the pre-test probability of obstruction is low but concern about the possibility exists, either ultrasound or MRCP is the first-line test, because of patient convenience and low complication rates.  MRCP findings are likely to be accepted without proceeding to ERCP or PTC. Of the two, UT is less expensive, though less definitive.

Situation 3: Indeterminate Likelihood of Obstruction

In this clinical situation, the patient's presentation is confusing, and the imaging work-up frequently is geared to the dominant clinical symptom. Ultrasound is an inexpensive, relatively accurate method, certainly appropriate if the sole question is whether or not obstruction exists. In cases in which most of the abdominal organs need to be assessed, either CT or MRI can be used, though CT more reliably displays all abdominal anatomy. When computed tomography evaluation is compromised (e.g., in patients unable to receive iodinated intravenous contrast material), the combination of MR and MRCP is a reliable alternative.

In summary, the diagnostic approach  for adults presenting with jaundice depends to a large extent on (a) the pre-imaging probability that the jaundice is obstructive rather than nonobstructive; (b) the pre-test probability that the most likely cause is benign versus malignant; and (c) whether the patient is an operative candidate, once the diagnosis is made. Lastly, the availability of each possible modality and the expertise with which it is offered are important considerations in any clinical situation.

Abbreviations

  • CT, computed tomography
  • ERCP, endoscopic retrograde cholangiopancreatography
  • EUS, endoscopic ultrasound
  • INV, invasive
  • MRCP, magnetic resonance cholangiopancreatography
  • MRI, magnetic resonance imaging
  • NUC, nuclear medicine
  • PTC, percutaneous transhepatic cholangiography
  • US, ultrasound

CLINICAL ALGORITHM(S)

Algorithms were not developed from criteria guidelines.

EVIDENCE SUPPORTING THE RECOMMENDATIONS

TYPE OF EVIDENCE SUPPORTING THE RECOMMENDATIONS

The recommendations are based on analysis of the current literature and expert panel consensus.

IDENTIFYING INFORMATION AND AVAILABILITY

BIBLIOGRAPHIC SOURCE(S)

  • Foley WD, Bree RL, Gay SB, Glick SN, Heiken JP, Huprich JE, Levine MS, Ros PR, Rosen MP, Shuman WP, Greene FL, Expert Panel on Gastrointestinal Imaging. Jaundice. [online publication]. Reston (VA): American College of Radiology (ACR); 2005. 6 p. [24 references]

ADAPTATION

Not applicable: The guideline was not adapted from another source.

DATE RELEASED

1996 (revised 2005)

GUIDELINE DEVELOPER(S)

American College of Radiology - Medical Specialty Society

SOURCE(S) OF FUNDING

American College of Radiology (ACR) provided the funding and the resources for these ACR Appropriateness Criteria®.

GUIDELINE COMMITTEE

Committee on Appropriateness Criteria, Expert Panel on Gastrointestinal Imaging

COMPOSITION OF GROUP THAT AUTHORED THE GUIDELINE

Panel Members: W. Dennis Foley, MD; Robert L. Bree, MD, MHSA (Panel Chair); Spencer B. Gay, MD; Seth N. Glick, MD; Jay P. Heiken, MD; James E. Huprich, MD; Marc S. Levine, MD; Pablo R. Ros, MD, MPH; Max Paul Rosen, MD, MPH; William P. Shuman, MD; Frederick L. Greene, MD

FINANCIAL DISCLOSURES/CONFLICTS OF INTEREST

Not stated

GUIDELINE STATUS

This is the current release of the guideline.

This guideline updates a previous version: Balfe DM, Ralls PW, Bree RL, DiSantis DJ, Glick SN, Levine MS, Megibow AJ, Saini S, Shuman WP, Greene FL, Laine LA, Lillemoe K, Kidd R. Imaging strategies in the initial evaluation of the jaundiced patient. American College of Radiology. ACR Appropriateness Criteria. Radiology 2000 Jun;215(Suppl):125-33.

The appropriateness criteria are reviewed annually and updated by the panels as needed, depending on introduction of new and highly significant scientific evidence.

GUIDELINE AVAILABILITY

Electronic copies: Available in Portable Document Format (PDF) from the American College of Radiology (ACR) Web site.

ACR Appropriateness Criteria® Anytime, Anywhere™ (PDA application). Available from the ACR Web site.

Print copies: Available from the American College of Radiology, 1891 Preston White Drive, Reston, VA 20191. Telephone: (703) 648-8900.

AVAILABILITY OF COMPANION DOCUMENTS

PATIENT RESOURCES

None available

NGC STATUS

This summary was completed by ECRI on March 19, 2001. The information was verified by the guideline developer on March 29, 2001. This NGC summary was updated by ECRI on January 26, 2006.

COPYRIGHT STATEMENT

DISCLAIMER

NGC DISCLAIMER

The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.

All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.

Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the NGC Inclusion Criteria which may be found at http://www.guideline.gov/about/inclusion.aspx .

NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.

Readers with questions regarding guideline content are directed to contact the guideline developer.


 

 

   
DHHS Logo